NL-OMON40696已完成不适用
Evaluation of changes in gut transit time and gastrointestinal symptoms following the consumption of a fiber containing product in adults with constipation. - Fibers and Gut Health
estec0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult men or women (female subjects of child-bearing potential must be willing to use a reliable method of contraception throughout the study period)
- •Age 18 - 75
- •BMI: 18.5 - 29.9 kg/m2
- •Symptoms of constipation for a minimum of 3 months
- •Recruitment based on simplified core ROME III diagnostic criteria for functional constipation (based on specific screening questions):
- •o average Bristol stool type of 1 - 3 AND frequency of 1 - 3 spontaneous bowel movements (SBMs) per week
- •o plus at least ONE of the following at screening:
- •* straining on at least 25% of defaecations
- •* sensation of incomplete evacuation on at least 25% of defaecations
- •* sensation of anorectal obstruction / blockage on at least 25% of defaecations
- •* use of manual manoeuvres on at least 25% of defaecations.
- •Cleveland Clinic constipation score (CCCS) of 8-20
- •Low-moderate fibre intake (<=18g) determined by the semi-quantitative food intake screener known as the Block Fibre Screener
- •Ability to understand the patient information sheet and instructions in Dutch, and able to provide informed consent
排除标准
- •Subjects who report lactose intolerance and/or are allergic to soy or cow milk protein
- •Pregnant or breast-feeding women
- •Ongoing other diagnosed gastrointestinal disease or complication (Crohn's disease, Coeliac disease, chronic diarrhoea)
- •Any clinical relevant abnormalities in the screening visit medical examination or alarm features such as sudden unintentional weight loss, rectal bleeding, recent change in bowel habit (<3 months), abdominal pain and stool positive for occult blood
- •Prior abdominal surgery (including gastric bypass or laparoscopic banding), except cholecystectomy and appendicectomy
- •Neurologic diseases such as multiple sclerosis, stroke, spinal cord injury, Hirschsprung disease
- •Chronic medication that in opinion of the investigator would impact gut motility
- •Illness that may preclude the subject's ability to complete the study or that may confound the study outcomes (e.g. bowel cancer, prostate cancer, terminal illness, severe cardiovascular disease, chronic renal failure or eating disorders) or any other serious illness resulting in >2 weeks inability to work in the 3 months before the study start
- •Subjects with co-morbid illnesses such as cardiovascular, endocrine, renal or other chronic disease likely to affect gut motility or limit normal functions (e.g. reduced mobility or increased fragility)
- •Ongoing alcohol, drug, or medication abuse (anamnesis only)
- •Self-reported symptoms of pelvic organ prolapse
- •Moderate or severe active local anorectal problems such as recurrent anal fissures, bleeding, large prolapsing haemorrhoids, etc
- •Regular use of fibre supplementation (e.g. Fybogel, Lactulose) over the week prior to the screening visit and no more than 6 standard doses in the past 1 month prior to the screening visit
- •Participation in another study with any investigational product within 3 months of screening
- •Investigator believes that the participant is physically or mentally unfit to participate in the trial
研究者
相似试验
已完成
不适用
Effects of Changing Intestinal Transit Time on Gut Microbial Composition and MetabolismDiet, HealthyMetabolic DiseaseNCT06022302University of Copenhagen22
已完成
不适用
Fibers and Gut HealthConstipationNCT02234518Société des Produits Nestlé (SPN)120
已完成
不适用
Probiotics and Gut HealthConstipationNCT01874301Société des Produits Nestlé (SPN)120
招募中
不适用
Comparison of gastric and small-bowel transit time between Lubiprostone, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopyhealthy volunteersJPRN-UMIN000010965Gastroenterology Division, Yokohama City University Graduate School of Medicine6
招募中
不适用
Comparison of gastric and small-bowel transit time between Acotiamide, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopyhealthy volunteersJPRN-UMIN000010966Gastroenterology Division, Yokohama City University Graduate School of Medicine6